News Posts List
Nivolumab Tested For Safety In Kidney Cancer
06/06/2013
Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center presented a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma (mRCC) at the ASCO Annual Meeting.
Immunotherapy: New Weapon Against Cancer
06/05/2013
"Everything has shrunk," said the 62-year-old contractor from Wolcott, Connecticut, who still goes for treatment every two weeks and has regular scans to keep tabs on his progress. "Some of the tumors you can't even see."
Kidney Cancer News for June, 2013
06/04/2013
Can statin drugs help prevent kidney cancer? This edition also includes a link to videos that will help you to learn how to take your anti-cancer drug, along with information about side effects.
VIDEO: Learn how we fund cutting-edge research
06/01/2013
Kidney Cancer Association and Conquer Cancer Foundation work together to promote and sponsor research projects.
2013 ASCO Annual Meeting: Abstracts Related to RCC
06/01/2013
A pre-filtered list of abstracts related to renal cell carcinoma (RCC) from the 2013 Annual Meeting of the American Society of Clinical Oncology, held this week in Chicago.
Kidney Cancer CONNECT Patient Registry
05/29/2013
We have launched a patient registry for kidney cancer.
Lpath begins phase IIa single-arm trial of anti-cancer drug, ASONEP
05/28/2013
ASONEP is a humanized antibody that binds to and neutralizes sphingosine-1-phosphate (S1P). S1P is a bioactive lipid that has been validated as a drug target in multiple sclerosis and that has been shown to contribute to progression of several cancer types.
VIDEO: Managing Side Effects from Kidney Cancer Targeted Therapies
05/25/2013
Members of the Kidney Cancer Association Nurse Advisory Board discuss targeted therapies and management of side effects.
Presentations from Eighth European International Kidney Cancer Symposium
05/25/2013
View expert presentations and download Powerpoint slides from this important kidney cancer meeting held recently in Budapest, Hungary.